ACCME and Commercial Supporters Discuss Emerging CME Issues
The ACCME hosted a commercial supporters forum in January at its Chicago offices. ACCME executive staff and commercial supporters discussed current and emerging issues related to the health care environment and accredited CME, including the Food and Drug Administration (FDA) Risk Evaluation and Mitigation Strategy (REMS) for extended-release and long-acting opioid analgesics. Participants discussed the importance of the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME and explored strategies for supporting accredited CME that is independent from commercial influence.
The ACCME hosts commercial supporter forums on occasion to provide an opportunity for participants to address emerging issues related to the health care environment and accredited CME funding and to reinforce their commitment to ensuring that commercially supported CME advances public health and serves the public interest.